<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02098798</url>
  </required_header>
  <id_info>
    <org_study_id>REB13-0960</org_study_id>
    <nct_id>NCT02098798</nct_id>
  </id_info>
  <brief_title>Comparison of Surveillance Colonoscopy Techniques in Patients With IBD</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We propose a randomized controlled study to determine the detection rates of neoplasia with
      high definition colonoscopy alone, high definition dye spraying chromoendoscopy or High
      definition iSCAN virtual chromoendoscopy in patients with long standing colitis (8 years from
      diagnosis except primary sclerosing cholangitis when surveillance starts at diagnosis) CD or
      UC.

      We hypothesized that these novel endoscopic techniques using High definition colonoscopy with
      virtual chromoendoscopy -iScan 2 and 3 may be superior to high definition colonoscopy alone
      and similar to using dye spraying chromoendoscopy for detection of dysplasia and neoplasia in
      patients with long standing IBD.

      We will aim to demonstrate if we can avoid dye spraying during the procedure and save expense
      and considerable time.

      In addition, we can hope to produce evidence and inform the way in which we perform
      surveillance colonoscopy especially without large number of multiple random biopsies but only
      few targeted&quot; smart and intelligent&quot; biopsies using high definition colonoscopy with iSCAN
      technique as is already the European practice in several centres.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of neoplasia in the 3 cohorts - high definition colonoscopy, HD colonoscopy + iSCAN, HD colonoscopy + dye chromoendoscopy</measure>
    <time_frame>At the time of procedure</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">270</enrollment>
  <condition>Inflammatory Bowel Disease</condition>
  <arm_group>
    <arm_group_label>HD</arm_group_label>
    <description>High Definition Colonoscopy alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HD + iSCAN</arm_group_label>
    <description>HD colonoscopy + iSCAN</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HD + Dye</arm_group_label>
    <description>High definition colonoscopy + dye spraying chromoendoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>HD Colonoscopy</intervention_name>
    <description>High definition colonoscopy procedure in surveillance colonoscopy</description>
    <arm_group_label>HD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>HD Colonoscopy + iSCAN</intervention_name>
    <arm_group_label>HD + iSCAN</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>HD Colonoscopy + dye spray</intervention_name>
    <arm_group_label>HD + Dye</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Inflammatory bowel disease patients undergoing surveillance colonoscopy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical and histological diagnosis of UC or colonic CD-extensive or pancolitis.

        UC -CD Disease duration 8 years from diagnosis UC-CD with associated primary sclerosing
        cholangitis from diagnosis Ulcerative Colitis Activity Index Mayo score 0-1 (inactive
        disease) Crohn's disease Activity Index - Harvey Bradshaw score &lt;4 (dysplasia detection
        requires quiescent inflammatory bowel disease)

        Exclusion Criteria:

        Known intraepithelial neoplasia or colorectal cancer or other neoplasia Coagulopathy which
        may prevent biopsies Pregnancy Inability to obtain informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Calgary, Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2014</study_first_submitted>
  <study_first_submitted_qc>March 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2014</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Iacucci Marietta MD,PhD</investigator_full_name>
    <investigator_title>Clinical Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Dysplasia, Inflammatory Bowel Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

